MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: A prospective validation study

International Journal of Cardiology

Volumn 156, Issue 1, 2012, Pages 16-23

  Vazquez, Miriam ^a,b   Jockers, Katharina ^a   Christ Crain, Mirjam ^a   Zimmerli, Werner ^b   Müller, Beat ^b   Schuetz, Philipp ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Atrial natriuretic peptide; Infection; Pneumonia; Risk prediction

Indexed keywords

ATRIAL NATRIURETIC FACTOR; MID REGIONAL PRO ATRIAL NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ADULT; ADVERSE OUTCOME; AGED; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMONIA SEVERITY INDEX; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858069703     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.037     Document Type: Article

References (46)

1. M.S. Niederman, L.A. Mandell, and A. Anzueto Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention Am. J. Respir. Crit. Care Med. 163 2001 1730 1754 (Pubitemid 32578779)
2. M.J. Fine, L.J. Hough, and A.R. Medsger The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study Arch. Intern. Med. 157 1997 36 44 (Pubitemid 27027073)
3. P. Schuetz, M. Koller, and M. Christ-Crain Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings Epidemiol. Infect. 136 2008 1628 1637
4. P. Schuetz, M. Christ-Crain, and B. Muller Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections - hope for hype? Swiss Med. Wkly 139 2009 318 326
5. K.N. Pandey Biology of natriuretic peptides and their receptors Peptides 26 2005 901 932 (Pubitemid 40725366)
6. de Bold A.J. Atrial natriuretic factor: a hormone produced by the heart Sci. NY NY 230 1985 767 770 (Pubitemid 16193965)
7. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N. Engl. J. Med. 339 1998 321 328 (Pubitemid 28366422)
8. T. Boldanova, M. Noveanu, and T. Breidthardt Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study Int. J. Cardiol. 142 2010 265 272
9. P. Faggiano, R. Valle, and N. Aspromonte Dei Cas L: How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification Int. J. Cardiol. 140 2010 88 94
10. N.A. Smart, and M. Steele Systematic review of the effect of aerobic and resistance exercise training on systemic brain natriuretic peptide (BNP) and N-terminal BNP expression in heart failure patients Int. J. Cardiol. 140 2010 260 265
11. A. Maisel, J.E. Hollander, and D. Guss Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J. Am. Coll. Cardiol. 44 2004 1328 1333 (Pubitemid 39208893)
12. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N. Engl. J. Med. 347 2002 161 167 (Pubitemid 34764819)
13. W.E. Hopkins, Z. Chen, N.K. Fukagawa, C. Hall, H.J. Knot, and M.M. LeWinter Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion Circulation 109 2004 2872 2877 (Pubitemid 38780301)
14. F. Lordick, R.W. Hauck, R. Senekowitsch, and H.P. Emslander Atrial natriuretic peptide in acute hypoxia-exposed healthy subjects and in hypoxaemic patients Eur. Respir. J. 8 1995 216 221
15. U. Hoffmann, M. Brueckmann, and T. Bertsch Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients Clin. Lab. 51 2005 373 379 (Pubitemid 41179670)
16. M. Brueckmann, G. Huhle, and S. Lang Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis Circulation 112 2005 527 534 (Pubitemid 41060793)
17. R. Witthaut, C. Busch, and P. Fraunberger Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction Intensive Care Med. 29 2003 1696 1702 (Pubitemid 37373812)
18. Morgenthaler N.G., Struck J., Christ-Crain M., Bergmann A., and Muller B. Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study Crit. care Lond. Engl. 9 2005 R37 R45
19. N.G. Morgenthaler, J. Struck, B. Thomas, and A. Bergmann Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin. Chem. 50 2004 234 236 (Pubitemid 38125732)
20. R. Seligman, J. Papassotiriou, N.G. Morgenthaler, M. Meisner, and P.J. Teixeira Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia Intensive Care Med. 34 2008 2084 2091
21. M. Masia, J. Papassotiriou, N.G. Morgenthaler, I. Hernandez, C. Shum, and F. Gutierrez Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia Clin. Chem. 53 2007 2193 2201 (Pubitemid 350197304)
22. S. Kruger, J. Papassotiriou, and R. Marre Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ Intensive Care Med. 33 2007 2069 2078 (Pubitemid 350164580)
23. C. Prat, A. Lacoma, and J. Dominguez Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia J. Infect. 55 2007 400 407 (Pubitemid 47611511)
24. B. Muller, E. Suess, and P. Schuetz Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections J. Intern. Med. 260 2006 568 576 (Pubitemid 44772377)
25. S. Kruger, S. Ewig, J. Kunde, O. Hartmann, N. Suttorp, and T. Welte Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ Thorax 65 2010 208 214
26. P. Schuetz, M. Christ-Crain, and M. Wolbers Effect of Procalcitonin-based Guidelines Compared to Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections: The Randomized-Controlled Multicenter ProHOSP Trial JAMA 302 2009 1059 1066
27. P. Schuetz, M. Christ-Crain, and M. Wolbers Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial BMC Health Serv. Res. 7 2007 102
28. P.M. Calverley, and P. Walker Chronic obstructive pulmonary disease Lancet 362 2003 1053 1061 (Pubitemid 37186885)
29. R. Gonzales, and M.A. Sande Uncomplicated acute bronchitis Ann. Intern. Med. 133 2000 981 991 (Pubitemid 32003514)
30. M. Woodhead, F. Blasi, and S. Ewig Guidelines for the management of adult lower respiratory tract infections Eur. Respir. J. 26 2005 1138 1180 (Pubitemid 41829947)
31. N.R. Anthonisen, J. Manfreda, C.P. Warren, E.S. Hershfield, G.K. Harding, and N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann. Intern. Med. 106 1987 196 204 (Pubitemid 17009877)
32. M.J. Fine, T.E. Auble, and D.M. Yealy A prediction rule to identify low-risk patients with community-acquired pneumonia N. Engl. J. Med. 336 1997 243 250 (Pubitemid 27044625)
33. A. Maisel, C. Mueller, and R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J. Am. Coll. Cardiol. 55 2010 2062 2076
34. M.R. Cowie, A.D. Struthers, and D.A. Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353 (Pubitemid 28036901)
35. T.A. McDonagh, S.D. Robb, and D.R. Murdoch Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13 (Pubitemid 28020159)
36. H. Ruskoaho Cardiac hormones as diagnostic tools in heart failure Endocr. Rev. 24 2003 341 356 (Pubitemid 36724374)
37. S. von Haehling, E.A. Jankowska, and N.G. Morgenthaler Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure J. Am. Coll. Cardiol. 50 2007 1973 1980 (Pubitemid 350046336)
38. A. Rudiger, M. Fischler, and P. Harpes In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts Int. J. Cardiol. 126 2008 28 31 (Pubitemid 351509624)
39. M. Haviv, E. Haver, D. Lichtstein, H. Hurvitz, and A. Klar Atrial natriuretic peptide in children with pneumonia Pediatr. Pulmonol. 40 2005 306 309 (Pubitemid 41437607)
40. D. Aronsky, and N.C. Dean How should we make the admission decision in community-acquired pneumonia? Med. Clin. North Am. 85 2001 1397 1411 (Pubitemid 32980010)
41. B.M. Farr, A.J. Sloman, and M.J. Fisch Predicting death in patients hospitalized for community-acquired pneumonia Ann. Intern. Med. 115 1991 428 436
42. M.J. Fine, D.E. Singer, B.H. Hanusa, J.R. Lave, and W.N. Kapoor Validation of a pneumonia prognostic index using the MedisGroups Comparative Hospital Database Am. J. Med. 94 1993 153 159 (Pubitemid 23046440)
43. M.A. Garcia-Ordonez, J.M. Garcia-Jimenez, and F. Paez Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia Eur. J. Clin. Microbiol. Infect. Dis. 20 2001 14 19 (Pubitemid 32200356)
44. D. Aronsky, and P.J. Haug Assessing the quality of clinical data in a computer-based record for calculating the pneumonia severity index J. Am. Med. Inform. Assoc. 7 2000 55 65 (Pubitemid 30041731)
45. W.S. Lim, M.M. van der Eerden, and R. Laing Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382 (Pubitemid 36560938)
46. A.J. Coats Ethical authorship and publishing Int. J. Cardiol. 131 2009 149 150